You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 280 No. 20, November 25, 1998 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Pediatrics
 •Adolescent Medicine
 •Psychiatry
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Child Psychopharmacology Comes of Age

Judith L. Rapoport, MD

JAMA. 1998;280:1785-1786.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In this issue of THE JOURNAL, March et al1 report the results of a multicenter, double-blind, placebo-controlled trial of sertraline hydrochloride for the treatment of obsessive-compulsive disorder (OCD) in children and adolescents. This article is gratifying in several ways. Obsessive-compulsive disorder has its onset in childhood or adolescence in approximately 50% of cases, and at least half of these cases benefit significantly from drug treatment.2 The study by March et al1 now extends to 3 the number of serotonin uptake–inhibiting drugs that have been demonstrated to be effective in children and adolescents in large multicenter trials. The others are clomipramine3 and fluvoxamine,4 and these 3 agents now have US Food and Drug Administration (FDA) approval for use in children and adolescents. In addition, 1 other selective serotonin reuptake inhibitor, fluoxetine, has been shown to be effective for childhood OCD in small controlled trials.5 Because OCD is . . . [Full Text of this Article]

From the Child Psychiatry Branch, National Institutes of Health, Bethesda, Md.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Sertraline in Children and Adolescents With Obsessive-Compulsive Disorder: A Multicenter Randomized Controlled Trial
John S. March, Joseph Biederman, Robert Wolkow, Allan Safferman, Jack Mardekian, Edwin H. Cook, Neal R. Cutler, Roberto Dominguez, James Ferguson, Betty Muller, Robert Riesenberg, Murray Rosenthal, Floyd R. Sallee, and Karen D. Wagner
JAMA. 1998;280(20):1752-1756.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Sertraline Effectively Treats Children with OCD
JWatch General 1998;1998:8-8.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.